| Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone H Mahmoudvand, R Tavakoli, F Sharififar, K Minaie, B Ezatpour, ... Pharmaceutical Biology 53 (7), 1052-1057, 2015 | 91 | 2015 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 71 | 2024 |
| Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica H Mahmoudvand, F Sharififar, MS Rahmat, R Tavakoli, ES Dezaki, ... Journal of vector borne diseases 51 (4), 294-299, 2014 | 68 | 2014 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 65 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 65 | 2024 |
| In vitro study of leishmanicidal activity of biogenic selenium nanoparticles against Iranian isolate of sensitive and glucantime-resistant Leishmania tropica H Mahmoudvand, M Shakibaie, R Tavakoli, S Jahanbakhsh, I Sharifi Iranian journal of parasitology 9 (4), 452, 2014 | 64 | 2014 |
| Efficacy and Safety of Bunium Persicum (Boiss) to Inactivate Protoscoleces during Hydatid Cyst Operations H Mahmoudvand, R Tavakoli Oliaei, SR Mirbadie, F Kheirandish, ... Surgical infections 17 (6), 713-719, 2016 | 59 | 2016 |
| Efficacy of the Bunium persicum (Boiss) essential oil against acute toxoplasmosis in mice model AT Kareshk, A Keyhani, H Mahmoudvand, RT Oliaei, A Asadi, ... Iranian journal of parasitology 10 (4), 625, 2015 | 59 | 2015 |
| Prevalence and risk factors of pediculosis in primary school children in South West of Iran J Nejati, A Keyhani, AT Kareshk, H Mahmoudvand, A Saghafipour, ... Iranian journal of public health 47 (12), 1923, 2018 | 57 | 2018 |
| Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling RT Oliaee, I Sharifi, A Afgar, AT Kareshk, A Asadi, A Heshmatkhah, ... Tropical Medicine & International Health 23 (6), 622-633, 2018 | 46 | 2018 |
| In vitro protoscolicidal effects of Cinnamomum zeylanicum essential oil and its toxicity in mice H Mahmoudvand, H Mahmoudvand, RT Oliaee, AT Kareshk, SR Mirbadie, ... Pharmacognosy magazine 13 (Suppl 3), S652, 2017 | 45 | 2017 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 32 | 2024 |
| The potential role and apoptotic profile of three medicinal plant extracts on Leishmania tropica by MTT assay, macrophage model and flow cytometry analysis M Ilaghi, I Sharifi, F Sharififar, F Sharifi, RT Oliaee, Z Babaei, ... Parasite Epidemiology and Control 12, e00201, 2021 | 32 | 2021 |
| Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 … M Bamorovat, I Sharifi, MR Aflatoonian, B Sadeghi, A Shafiian, RT Oliaee, ... International immunopharmacology 69, 321-327, 2019 | 30 | 2019 |
| Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica M Bamorovat, I Sharifi, R Tavakoli Oliaee, A Jafarzadeh, A Khosravi Frontiers in Microbiology 12, 638957, 2021 | 20 | 2021 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 19 | 2023 |
| In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and … A Keyhani, I Sharifi, E Salarkia, A Khosravi, RT Oliaee, Z Babaei, ... International Immunopharmacology 101, 108274, 2021 | 18 | 2021 |
| A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models M Bamorovat, I Sharifi, A Fekri, A Keyhani, MR Aflatoonian, ... Microbial pathogenesis 128, 162-170, 2019 | 17 | 2019 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 16 | 2024 |
| Host-parasite responses outcome regulate the expression of antimicrobial peptide genes in the skin of balb/c and c57bl/6 murine strains following leishmania major mrho/ir/75/er … H Daneshvar, AT Kareshk, I Sharifi, A Keyhani, RT Oliaee, A Asadi Iranian Journal of Parasitology 13 (4), 515, 2018 | 16 | 2018 |
